Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656560903329102
Reference118 articles.
1. Mecamylamine: new therapeutic uses and toxicity/risk profile
2. What is the nature of mecamylamine's antagonism of the central effects of nicotine?
3. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
4. Nicotine and Nicotinic Receptor Involvement in Neuropsychiatric Disorders
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A tailed mirtron promotes longevity in Drosophila;Nucleic Acids Research;2023-12-04
2. Long-Term—But Not Short-Term—Plasticity at the Mossy Fiber–CA3 Pyramidal Cell Synapse in Hippocampus Is Altered in M1/M3 Muscarinic Acetylcholine Receptor Double Knockout Mice;Cells;2023-07-19
3. Optogenetic stimulation of the brainstem dorsal motor nucleus ameliorates acute pancreatitis;Frontiers in Immunology;2023-04-25
4. Prenatal Hypoxia Affects Nicotine Consumption and Withdrawal in Adult Rats via Impairment of the Glutamate System in the Brain;Molecular Neurobiology;2022-05-17
5. Co‐administration of morphine and levamisole increases death risk, produces neutropenia and modifies antinociception in mice;Addiction Biology;2022-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3